Myeloperoxidase as a Potential Biomarker of Acute-Myocardial-Infarction-Induced Depression and Suppression of the Innate Immune System
While myeloperoxidase (MPO) serves as an indicator of both neutrophil and innate-immune-system function, the potential suppression of the innate immune system in patients with acute myocardial infarction (AMI)-induced depression might be evidenced by a decrease in MPO serum levels. The aim of this p...
Main Authors: | Andreas Baranyi, Dietmar Enko, Andreas Meinitzer, Dirk Von Lewinski, Hans-Bernd Rothenhäusler, Leonhard Harpf, Heimo Traninger, Barbara Obermayer-Pietsch, Birgit M. Harb, Melanie Schweinzer, Moritz Platzer, Sieglinde Zelzer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/11/2083 |
Similar Items
-
Assessment of trimethylamine N-oxide (TMAO) as a potential biomarker of severe stress in patients vulnerable to posttraumatic stress disorder (PTSD) after acute myocardial infarction
by: Andreas Baranyi, et al.
Published: (2021-01-01) -
Sex-specific differences in trimethylamine N-oxide (TMAO) concentrations before and after cardiac rehabilitation in acute myocardial infarction patients
by: Andreas Baranyi, et al.
Published: (2022-01-01) -
Myeloperoxidase as a Marker to Differentiate Mouse Monocyte/Macrophage Subsets
by: Cody J. Gurski, et al.
Published: (2022-07-01) -
Effects of Synthetic Short Cationic Antimicrobial Peptides on the Catalytic Activity of Myeloperoxidase, Reducing Its Oxidative Capacity
by: Tatyana V. Vakhrusheva, et al.
Published: (2022-12-01) -
Toxoplasma chorioretinitis in primary myeloperoxidase MPO deficiency: A case report
by: D.V. Maltsev, et al.
Published: (2019-08-01)